RNA Splicing Factors Linked to Aggressiveness in Mantle Cell Lymphoma | Potential for New Therapeutic Strategies

In this episode of SciBud, join your host Maple as we explore a groundbreaking study on mantle cell lymphoma (MCL), an aggressive blood cancer that poses significant treatment challenges. Recent research highlights the vital role of RNA splicing factors—proteins that assist in editing messenger RNA— in the progression of MCL, revealing that their dysregulation contributes to cancer's tenacity. By profiling splicing factor expression in cancerous versus normal B cells, scientists identified key players like SRSF1, hnRNP F, and PTBP1, which, when diminished through CRISPR techniques, led to reduced cell growth and increased cancer cell death. These findings not only deepen our understanding of MCL but also suggest potential avenues for new therapies, potentially transforming the outlook for patients. Tune in for insights on this pivotal research, its implications for cancer treatment, and how we continue to uncover the mysteries of the human body through science! Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/309